Akero Therapeutics, Inc.
← Back to AKRO Overview

Akero Therapeutics, Inc. (AKRO)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-11.93

Financial Fundamentals

AKROQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2017-12-31-111.08
2018-03-31-230.90
2018-06-30-11.21
2018-09-30-8.72
2018-12-31-1.58
2019-03-31-22.46
2019-06-30-17.88
2019-09-30-10.25
2019-12-31-10.07
2020-03-31-12.71
2020-06-30-11.00
2020-09-30-12.23
2020-12-31-7.53
2021-03-31-16.70
2021-06-30-7.46
2021-09-30-8.01
2021-12-31-5.69
2022-03-31-4.77
2022-06-30-3.05
2022-09-30-9.26
2022-12-31-27.78
2023-03-31-17.38
2023-06-30-19.48
2023-09-30-17.73
2023-12-31-5.89
2024-03-31-6.69
2024-06-30-7.15
2024-09-30-6.85
2024-12-31-7.01
2025-03-31-11.25
2025-06-30-15.46
2025-09-30-11.93

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.